viewOptos Plc

Optos reports strong full-year profits and looks ahead with confidence


Medical retinal imaging technology company Optos PLC reported strong sales and profits rises for the full-year to the end of September 2008 and is looking ahead with confidence despite challenging economic times.

It made a pretax profit of US$5.9 million, up from US$1.6 million, on sales of US$100.8 million, a 16 percent rise from the US$86.8 million it posted a year earlier.     

The period under review saw 14 percent growth in North America revenue, 61 percent in European revenue, and the number of devices installed worldwide rose 18 percent from the previous year to 3,983.

Optos' devices produce ultra wide-field, high resolution images of approximately 82 percent of the retina, something the company claims no other device is capable of doing in any one image. The images provide optometrists and ophthalmologists with enhanced clinical information which facilitates the early detection, management and treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy and age-related macular degeneration.

Quick facts: Optos Plc

Price: 0 0

Market: AIM
Market Cap: £0.00

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Tlou Energy's Tony Gilby updates on Lesedi production ahead...

Tlou Energy Limited’s (LON:TLOU) Tony Gilby speaks to Proactive London's Andrew Scott ahead a site visit next week. He says they've made an excellent start to flow testing at its Botswana coal bed methane wells. Gilby adds that, like most new CBM wells, the Lesedi operation is expected to...

55 minutes ago

2 min read